We've found
					184,457 				
					clinical trials				
				
			
		
							
  	
	Oncology Clinical Trial
	Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	Pivotal Study Of A Dual Epicardial & Endocardial Procedure (DEEP) Approach
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	Pivotal Study Of A Dual Epicardial & Endocardial Procedure (DEEP) Approach
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Crohn Disease Clinical Trial
	A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Crohn Disease Clinical Trial
	A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Crohn Disease Clinical Trial
	A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Crohn Disease Clinical Trial
	A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Crohn Disease Clinical Trial
	A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Crohn Disease Clinical Trial
	A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Crohn Disease Clinical Trial
	A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Crohn Disease Clinical Trial
	A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Crohn Disease Clinical Trial
	A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Crohn Disease Clinical Trial
	A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Crohn Disease Clinical Trial
	A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Crohn Disease Clinical Trial
	A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Crohn Disease Clinical Trial
	A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Crohn Disease Clinical Trial
	A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Crohn Disease Clinical Trial
	A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Crohn Disease Clinical Trial
	A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Crohn Disease Clinical Trial
	A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Crohn Disease Clinical Trial
	A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Nab-Paclitaxel, Capecitabine, and Radiation Therapy Following Induction Chemotherapy in Treating Patients With Locally Advanced Pancreatic Cancer
		Status: Enrolling,
							Phase
													 I			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Diabetes Mellitus Clinical Trial
	Alveolar Bone Changes in Diabetes (ABCD) Study
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/14/2017	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Hypoplastic Left Heart Syndrome Clinical Trial
	Allogeneic hMSC Injection in Patients With Hypoplastic Left Heart Syndrome
		Status: Enrolling,
							Phase
													 I			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	FES PET/CT in Predicting Response in Patients With Newly Diagnosed Metastatic Breast Cancer Receiving Endocrine Therapy
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	FES PET/CT in Predicting Response in Patients With Newly Diagnosed Metastatic Breast Cancer Receiving Endocrine Therapy
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	COPD Clinical Trial
	The Trajectory of Physical Activity Following Pulmonary Rehabilitation
		Status: Enrolling	
	
	
			Updated: 1/3/2017	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Subclinical Hypothyroidism Clinical Trial
	Mechanistic Study of Subclinical Hypothyroidism In the Elderly
		Status: Enrolling	
	
	
			Updated: 4/27/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Endocrinology, Gastroenterology, Orthopedics / Podiatry Clinical Trial
	Study of Amniotic Membrane Graft in the Management of Diabetic Foot Ulcers
		Status: Enrolling	
	
	
			Updated: 3/25/2015	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Endocrinology, Gastroenterology, Orthopedics / Podiatry Clinical Trial
	Study of Amniotic Membrane Graft in the Management of Diabetic Foot Ulcers
		Status: Enrolling	
	
	
			Updated: 3/25/2015	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Colorectal Liver Metastasis Clinical Trial
	Health Related Quality of Life Following Hepatectomy for Colorectal Liver Metastasis: Global and Disease Specific Changes Over Time
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Acute Myeloid Leukemia Clinical Trial
	Crenolanib Maintenance Following Allogeneic Stem Cell Transplantation in FLT3-positive Acute Myeloid Leukemia Patients
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Early Stage HER2+ Breast Cancer Clinical Trial
	A Study Looking the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and Loperamide
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Early Stage HER2+ Breast Cancer Clinical Trial
	A Study Looking the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and Loperamide
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Early Stage HER2+ Breast Cancer Clinical Trial
	A Study Looking the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and Loperamide
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Early Stage HER2+ Breast Cancer Clinical Trial
	A Study Looking the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and Loperamide
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Relapsed Multiple Myeloma Clinical Trial
	ATRA, Celecoxib, and Itraconazole as Maintenance
		Status: Enrolling,
							Phase
													 I			
				
		
	
	
			Updated: 5/26/2015	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Nicotine Dependence Clinical Trial
	rTMS for Smoking Cessation
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Immunology / Infectious Diseases, Oncology, Reproductive Clinical Trial
	Preventive Sexual Health Screening Among Female-to-Male (FTM) Transgender Adult Patients
		Status: Enrolling	
	
	
			Updated: 8/9/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Endocrinology Clinical Trial
	The Role of Emotional Arousal in Food Preference and Taste
		Status: Enrolling	
	
	
			Updated: 1/10/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
	Project: Every Child for Younger Patients With Cancer
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
	Project: Every Child for Younger Patients With Cancer
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
	Project: Every Child for Younger Patients With Cancer
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
	Project: Every Child for Younger Patients With Cancer
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
	Project: Every Child for Younger Patients With Cancer
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
	Project: Every Child for Younger Patients With Cancer
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
	Project: Every Child for Younger Patients With Cancer
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
						
				
			
We've found
					184,457 
				
					clinical trials
				
				
				
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  Pivotal Study Of A Dual Epicardial & Endocardial Procedure (DEEP) Approach
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  Pivotal Study Of A Dual Epicardial & Endocardial Procedure (DEEP) Approach
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Crohn Disease Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Crohn Disease Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Crohn Disease Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Crohn Disease Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Crohn Disease Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Crohn Disease Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Crohn Disease Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Crohn Disease Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Crohn Disease Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Crohn Disease Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Crohn Disease Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Crohn Disease Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Crohn Disease Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Crohn Disease Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Crohn Disease Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Crohn Disease Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Crohn Disease Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Crohn Disease Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Nab-Paclitaxel, Capecitabine, and Radiation Therapy Following Induction Chemotherapy in Treating Patients With Locally Advanced Pancreatic Cancer
		Status: Enrolling,
							Phase
													 I			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Diabetes Mellitus Clinical Trial
	
Updated: 12/14/2017
  
  
  Alveolar Bone Changes in Diabetes (ABCD) Study
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/14/2017
Click here to add this to my saved trials
	    
		
	Hypoplastic Left Heart Syndrome Clinical Trial
	
Updated: 12/31/1969
  
  
  Allogeneic hMSC Injection in Patients With Hypoplastic Left Heart Syndrome
		Status: Enrolling,
							Phase
													 I			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  FES PET/CT in Predicting Response in Patients With Newly Diagnosed Metastatic Breast Cancer Receiving Endocrine Therapy
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  FES PET/CT in Predicting Response in Patients With Newly Diagnosed Metastatic Breast Cancer Receiving Endocrine Therapy
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	COPD Clinical Trial
	
Updated: 1/3/2017
  
  
  The Trajectory of Physical Activity Following Pulmonary Rehabilitation
		Status: Enrolling	
	Updated: 1/3/2017
Click here to add this to my saved trials
	    
		
	Subclinical Hypothyroidism Clinical Trial
	
Updated: 4/27/2018
  
  
  Mechanistic Study of Subclinical Hypothyroidism In the Elderly
		Status: Enrolling	
	Updated: 4/27/2018
Click here to add this to my saved trials
	    
		
	Endocrinology, Gastroenterology, Orthopedics / Podiatry Clinical Trial
	
Updated: 3/25/2015
  
  
  Study of Amniotic Membrane Graft in the Management of Diabetic Foot Ulcers
		Status: Enrolling	
	Updated: 3/25/2015
Click here to add this to my saved trials
	    
		
	Endocrinology, Gastroenterology, Orthopedics / Podiatry Clinical Trial
	
Updated: 3/25/2015
  
  
  Study of Amniotic Membrane Graft in the Management of Diabetic Foot Ulcers
		Status: Enrolling	
	Updated: 3/25/2015
Click here to add this to my saved trials
	    
		
	Colorectal Liver Metastasis Clinical Trial
	
Updated: 12/31/1969
  
  
  Health Related Quality of Life Following Hepatectomy for Colorectal Liver Metastasis: Global and Disease Specific Changes Over Time
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Acute Myeloid Leukemia Clinical Trial
	
Updated: 12/31/1969
  
  
  Crenolanib Maintenance Following Allogeneic Stem Cell Transplantation in FLT3-positive Acute Myeloid Leukemia Patients
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Early Stage HER2+ Breast Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study Looking the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and Loperamide
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Early Stage HER2+ Breast Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study Looking the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and Loperamide
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Early Stage HER2+ Breast Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study Looking the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and Loperamide
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Early Stage HER2+ Breast Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study Looking the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and Loperamide
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	Click here to add this to my saved trials
	    
		
	Relapsed Multiple Myeloma Clinical Trial
	
Updated: 5/26/2015
  
  
  ATRA, Celecoxib, and Itraconazole as Maintenance
		Status: Enrolling,
							Phase
													 I			
				
		
	Updated: 5/26/2015
Click here to add this to my saved trials
	    
		
	Nicotine Dependence Clinical Trial
	
Updated: 12/31/1969
  
  
  rTMS for Smoking Cessation
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Immunology / Infectious Diseases, Oncology, Reproductive Clinical Trial
	
Updated: 8/9/2016
  
  
  Preventive Sexual Health Screening Among Female-to-Male (FTM) Transgender Adult Patients
		Status: Enrolling	
	Updated: 8/9/2016
Click here to add this to my saved trials
	    
		
	Endocrinology Clinical Trial
	
Updated: 1/10/2018
  
  
  The Role of Emotional Arousal in Food Preference and Taste
		Status: Enrolling	
	Updated: 1/10/2018
Click here to add this to my saved trials
	    
		
	Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Project: Every Child for Younger Patients With Cancer
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Project: Every Child for Younger Patients With Cancer
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Project: Every Child for Younger Patients With Cancer
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Project: Every Child for Younger Patients With Cancer
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Project: Every Child for Younger Patients With Cancer
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Project: Every Child for Younger Patients With Cancer
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Project: Every Child for Younger Patients With Cancer
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials